| 1407521-37-2

• CAS: 1407521-37-2
• 化学式: C₃₉H₃₃Br₆N₉Ru₂
• 分子量: 1309.32
• InChiKey: HFSJSUWGKKUJPI-UHFFFAOYSA-H

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为产物：
  描述：

  ruthenium (III) bromide 、 2-(2-氨基苯基)苯并咪唑 以 丙酮 为溶剂， 反应 6.0h， 生成
  参考文献：
  名称：

  Syntheses, characterizations, and antimicrobial activities of binuclear ruthenium(III) complexes containing 2-substituted benzimidazole derivatives

  摘要：

  Binuclear ruthenium(III) complexes [RuX3L](2) center dot nH(2)O (X=Cl, L=L-1, L-2, L-3; n=1, L-4 and L-5, X=Br; L=L-3), [RuX3L1.5](2) center dot nH(2)O (X=Br, L=L-1; n=0, L-4; n=6 and L-5; n=10), and [RuX3L2](2) (X=Br, L=L-2) have been isolated by treatment of hydrated RuX3 (X=Cl/Br) in acetone with 2-(2 '-aminophenylbenzimidazole) (L-1), 2-(3 '-aminophenylbenzimidazole) (L-2), 2-[(3 '-N-salicylidinephenyl)benzimidazole] (L-3), 2-(3 '-pyridylbenzimidazole) (L-4), and 2-(4 '-pyridylbenzimidazole) (L-5) in acetone. The complexes were characterized by elemental analysis, conductivity and magnetic susceptibility measurements, IR, electronic, EPR, and mass spectral studies. The complexes were dimeric; based on analytical and spectral studies, an octahedral geometry was proposed for the complexes. The synthesized complexes were screened against Gram-positive and Gram-negative bacteria and fungi.

  DOI：

  10.1080/00958972.2012.731050